Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 1,815,000 | 1,787,000 | 1,774,203 | 1,821,748 | 1,878,352 |
| Cost of Goods | 1,094,000 | 1,092,000 | 1,072,895 | 1,081,017 | 1,101,924 |
| Gross Profit | 721,000 | 695,000 | 701,308 | 740,731 | 776,428 |
| Operating Expenses | 432,000 | 468,000 | 436,994 | 436,128 | 444,000 |
| Operating Income | 289,000 | 227,000 | 265,209 | 304,620 | 333,352 |
| Interest Expense | 40,000 | 40,000 | 40,339 | 40,809 | 41,750 |
| Other Income | 7,000 | 10,000 | 6,354 | 7,164 | 6,117 |
| Pre-tax Income | 256,000 | 197,000 | 231,224 | 270,975 | 297,719 |
| Income Tax | 95,000 | 73,000 | 81,734 | 103,978 | 113,726 |
| Net Income Continuous | 161,000 | 124,000 | 149,490 | 166,997 | 183,993 |
| Net Income Discontinuous | 13,000 | 20,000 | -84,016 | 4,541 | 2,480 |
| Minority Interests | 9,000 | 8,000 | 9,379 | 8,456 | 8,768 |
| Net Income | $165,000 | $136,000 | $56,095 | $163,082 | $177,705 |
| EPS Basic Total Ops | 1.07 | 0.86 | 0.35 | 1.02 | 1.12 |
| EPS Basic Continuous Ops | 0.99 | 0.73 | 0.89 | 0.99 | 1.10 |
| EPS Basic Discontinuous Ops | 0.08 | 0.13 | -0.54 | 0.03 | 0.02 |
| EPS Diluted Total Ops | 1.07 | 0.85 | 0.35 | 1.01 | 1.11 |
| EPS Diluted Continuous Ops | 0.99 | 0.72 | 0.88 | 0.98 | 1.09 |
| EPS Diluted Discontinuous Ops | 0.08 | 0.13 | -0.53 | 0.03 | 0.02 |
| EBITDA(a) | $361,000 | $297,000 | $336,909 | $375,891 | $405,207 |